Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.

Authors
Type
Published Article
Journal
Scandinavian Journal of Infectious Diseases
1651-1980
Publisher
Informa UK (Taylor & Francis)
Publication Date
Volume
42
Issue
11-12
Pages
885–889
Identifiers
DOI: 10.3109/00365548.2010.509333
PMID: 20735333
Source
Medline
License
Unknown

Abstract

Tobramycin and colistin represent 2 standard antimicrobial agents in the treatment of cystic fibrosis (CF) patients who are chronically colonized with Pseudomonas aeruginosa. In this study, we determined the rate of resistance to tobramycin and colistin in 1844 isolates of P. aeruginosa obtained from 22 CF patients under alternate therapy with inhaled tobramycin and colistin. Resistance to tobramycin was observed in 27.5% of isolates. In contrast, all isolates were susceptible to colistin. Molecular typing of selected isolates suggested that only 1 clone occurred over time in each patient. To conclude, resistance to tobramycin in P. aeruginosa isolates from CF patients under antimicrobial therapy may occur while colistin resistance remains uncommon.

Statistics

Seen <100 times